In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...

Immune checkpoint blockade therapies, including monoclonal antibodies targeting PD-1 and PD-L1 ... Several mechanisms have ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

Researchers at MUSC Hollings Cancer Center have identified a signaling loop involved in the growth and persistence of ...

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...

Researchers at MUSC Hollings Cancer Center have identified a signaling loop involved in the growth and persistence of ...